DURECT Corp
NASDAQ:DRRX

Watchlist Manager
DURECT Corp Logo
DURECT Corp
NASDAQ:DRRX
Watchlist
Price: 1.26 USD -2.33% Market Closed
Market Cap: 39.1m USD
Have any thoughts about
DURECT Corp?
Write Note

DURECT Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DURECT Corp
Cost of Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
DURECT Corp
NASDAQ:DRRX
Cost of Revenue
-$1.6m
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
9%
Johnson & Johnson
NYSE:JNJ
Cost of Revenue
-$26.9B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Cost of Revenue
-$11.1B
CAGR 3-Years
-4%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Pfizer Inc
NYSE:PFE
Cost of Revenue
-$16B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
-5%
Merck & Co Inc
NYSE:MRK
Cost of Revenue
-$15.1B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cost of Revenue
-$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-11%
CAGR 10-Years
-4%

See Also

What is DURECT Corp's Cost of Revenue?
Cost of Revenue
-1.6m USD

Based on the financial report for Jun 30, 2024, DURECT Corp's Cost of Revenue amounts to -1.6m USD.

What is DURECT Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
9%

Over the last year, the Cost of Revenue growth was 0%. The average annual Cost of Revenue growth rates for DURECT Corp have been -3% over the past three years , -3% over the past five years , and 9% over the past ten years .

Back to Top